Ligand Pharmaceuticals Incorporated Asset Turnover Ratio (LGND), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ligand Pharmaceuticals Incorporated  (NASDAQ: LGND)
 

Ligand Pharmaceuticals Incorporated Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Ligand Pharmaceuticals Incorporated's asset turnover ratio, the ratio that measures the ability of Ligand Pharmaceuticals Incorporated's assets to generate revenue, sequentially decreased to 0.13 in the third quarter (Sep 30 2026), which does not come as a surprise, as the Ligand Pharmaceuticals Incorporated continue to experience difficult business climate.

Within sector 148 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 2904, from total ranking in the second quarter 2026 at 3347.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LGND Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 45.76 % 129.58 % 68.77 % 99.78 % 54.8 %
Y / Y Revenue Change -31.8 % 33.73 % 14.09 % 40.01 % 122.85 %
Asset Turnover Ratio (TTM) 0.13 0.16 0.18 0.19 0.23
LGND's Total Ranking # 2904 # 3347 # 2867 # 3013 # 3081
Seq. Asset Change -1.34 % 42.67 % -30.01 % 47.95 % 55.39 %
Seq. Revenue Change 23.63 % 23.14 % -13.31 % -48.32 % 142.43 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 149
Healthcare Sector # 453
Overall Market # 2904

Asset Turnover Ratio Statistics
High Average Low
0.53 0.22 0.07
(Jun 30 2014)   (Dec 31 2019)




LGND Company Profile • Back to LGND Efficiency Comparisons • Compare LGND Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Krystal Biotech Inc   0.32 $ 470.025  Millions$ 1,454.366  Millions
Hyperfine Inc   0.31 $ 18.537  Millions$ 59.098  Millions
Orasure Technologies Inc  0.31 $ 116.113  Millions$ 373.089  Millions
Pfizer Inc  0.31 $ 63,625.000  Millions$ 205,363.250  Millions
Cardiff Lexington Corporation  0.30 $ 9.066  Millions$ 30.160  Millions
Ionis Pharmaceuticals Inc   0.30 $ 960.091  Millions$ 3,220.224  Millions
Adc Therapeutics Sa  0.30 $ 84.873  Millions$ 287.472  Millions
Sonida Senior Living Inc   0.29 $ 638.130  Millions$ 2,170.454  Millions
Fulgent Genetics Inc   0.29 $ 329.873  Millions$ 1,134.512  Millions
Waters Corporation  0.29 $ 5,611.362  Millions$ 19,618.388  Millions
Orchestra Biomed Holdings Inc   0.28 $ 31.206  Millions$ 109.738  Millions
Amarin Corp Plcuk  0.27 $ 176.609  Millions$ 643.746  Millions
Repligen Corp  0.27 $ 805.610  Millions$ 2,939.265  Millions
Humacyte Inc   0.27 $ 32.703  Millions$ 122.646  Millions
Neogen Corporation  0.26 $ 884.120  Millions$ 3,363.009  Millions
Autolus Therapeutics Plc  0.26 $ 137.434  Millions$ 533.104  Millions
Cryoport inc   0.25 $ 192.439  Millions$ 758.937  Millions
Bio rad Laboratories Inc   0.25 $ 2,593.000  Millions$ 10,350.400  Millions
Revvity Inc  0.25 $ 2,941.761  Millions$ 11,925.295  Millions
Coherus Oncology inc   0.24 $ 53.639  Millions$ 221.663  Millions
Abeona Therapeutics Inc   0.22 $ 41.912  Millions$ 192.374  Millions
Atara Biotherapeutics Inc   0.20 $ 4.019  Millions$ 19.966  Millions
Teleflex Incorporated  0.19 $ 1,283.675  Millions$ 6,716.220  Millions
Elutia Inc   0.18 $ 9.637  Millions$ 52.350  Millions
Maxcyte inc   0.18 $ 34.374  Millions$ 191.034  Millions
Septerna Inc   0.16 $ 96.268  Millions$ 588.004  Millions
Lexicon Pharmaceuticals Inc   0.16 $ 38.537  Millions$ 236.472  Millions
Wave Life Sciences Ltd   0.15 $ 87.296  Millions$ 572.074  Millions
Omniab Inc   0.14 $ 40.211  Millions$ 293.935  Millions
Standard Biotools Inc   0.14 $ 83.592  Millions$ 617.355  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.